eli lilly retatrutide and Company's triple agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C Retatrutide, Eli Lilly's next obesity
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25




























![Quick Booster [CBLZ-EN065] Ultimate Rare](https://galaxygamesllc.com/cdn/shop/files/1d45eba7-132f-55bc-a16f-b4bc850f0ed4.jpg?v=1776827902)